Identification of midkine as a mediator for intercellular transfer of drug resistance

Oncogene

Volumn 24, Issue 31, 2005, Pages 4965-4974

  Mirkin, Bernard L ^a,b   Clark, Sandra ^a   Zheng, Xin ^a   Chu, Fei ^a   White, Bryan D ^c   Greene, Marianne ^d   Rebbaa, Abdelhadi ^a,b,e  

^a Children's Memorial Research Center   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

^c UNIVERSITY OF WASHINGTON   (United States)

^d UNIVERSITY OF CHICAGO   (United States)

^e CHILDREN S MEMORIAL RESEARCH CENTER   (United States)

Author keywords

Akt; Apoptosis; Drug resistance; Midkine; p21 WAF1; Senescence

Indexed keywords

CASPASE 3; CYTOTOXIC AGENT; DOXORUBICIN; MIDKINE; PROTEIN KINASE B; PROTEIN P21;

AFFINITY CHROMATOGRAPHY; APOPTOSIS; ARTICLE; CELL PROTECTION; CELL SURVIVAL; CELL TRANSFER; CHEMOTHERAPY; CONTROLLED STUDY; DNA MICROARRAY; DRUG MECHANISM; DRUG SENSITIVITY; DRUG TARGETING; DRUG TRANSPORT; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN TRANSPORT; TUMOR RESISTANCE;

BIOLOGICAL TRANSPORT; CELL DIVISION; CELL LINE, TUMOR; CELL SURVIVAL; CYTOKINES; DOXORUBICIN; DRUG RESISTANCE, NEOPLASM; HUMANS; NERVE GROWTH FACTORS; NEUROBLASTOMA; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; TRANSFECTION;

EID: 23744517089     PISSN: 09509232     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.onc.1208671     Document Type: Article

References (36)

1. Chang BD, Swift ME, Shen M, Fang J, Broude EV and Roninson IB. (2002). Proc. Natl. Acad Sci. USA, 99, 389-394.
2. Dalton WS and Jove R. (1999). Semin. Oncol., 26, 23-27.
3. Debatin KM and Krammer PH. (2004). Oncogene, 23, 2950-2966.
4. Emran MA, Rebbaa A and Mirkin BL. (2002). Cancer Lett., 182, 53-59.
5. Fulda S and Debatin KM. (2003). Cancer Lett., 197, 131-135.
6. Gorre ME, Mohammed M, Ellwood K, Hsu N, Paquette R, Rao PN and Sawyers CL. (2001). Science, 293, 876-880.
7. Gottesman MM, Hrycyna CA, Schoenlein PV, Germann UA and Pastan I. (1995). Annu. Rev. Genet., 29, 607-649.
8. Hartmann A, Troadec JD, Hunot S, Kikly K, Faucheux BA, Mouatt-Prigent A, Ruberg M, Agid Y and Hirsch EC. (2001). J. Neurosci., 21, 2247-2255.
9. Hirano T, Ishihara K and Hibi M. (2000). Oncogene, 19, 2548-2556.
10. Ikematsu S, Nakagawara A, Nakamura Y, Sakuma S, Wakai K, Muramatsu T and Kadomatsu K. (2003). Br. J. Cancer, 88, 1522-1526.
11. Johnson DE. (1998). Front Biosci., 3, d313-d324.
12. Kang HC, Kim IJ, Park JH, Shin Y, Ku JL, Jung MS, Yoo BC, Kim HK and Park JG. (2004). Clin. Cancer Res., 10, 272-284.
13. Klein B, Tarte K, Jourdan M, Mathouk K, Moreaux J, Jourdan E, Legouffe E, De Vos J and Rossi JF. (2003). Int. J. Hematol., 18, 106-113.
14. Li Q, Ahmed S and Loeb JA. (2004). Cancer Res., 64, 7078-7085.
15. Luschen S, Ussat S, Scherer G, Kabelitz D and Adam-Klages S. (2000). J. Biol. Chem., 275, 24670-24678.
16. Martinsson P, Liminga G, Nygren P and Larsson R. (2001). Anticancer Drugs, 12, 699-705.
17. Masuda K, Watanabe I, Unoki K, Ohba N and Muramatsu T. (1995). Invest. Ophthalmol. Vis. Sci., 36, 2142-2146.
18. Muramatsu H and Muramatsu T. (1991). Biochem. Biophys. Res. Commun., 177, 652-658.
19. Muramatsu T. (1993). Int. J. Dev. Biol. 37, 183-188.
20. Muramatsu T. (2002). J. Biochem. (Tokyo). 132, 359-371.
21. Owada K, Sanjo N, Kobayashi T, Mizusawa H, Muramatsu H, Muramatsu T and Michikawa M. (1999). J. Neurochem., 73, 2084-2092.
22. Pommier Y, Sordet O, Antony S, Hayward RL and Kohn KW. (2004). Oncogene, 23, 2934-2949.
23. Qi M, Ikematsu S, Ichihara-Tanaka K, Sakuma S, Muramatsu T and Kadomatsu K. (2000). J. Biochem. (Tokyo), 127, 269-277.
24. Ratovitski EA, Kotzbauer PT, Milbrandt J, Lowenstein CJ and Burrow CR. (1998). J. Biol. Chem., 273, 3654-3660.
25. Rebbaa A, Chou PM and Mirkin BL. (2001). Mol. Med., 7, 393-400.
26. Rebbaa A, Zheng X, Chou PM and Mirkin BL. (2003). Oncogene, 22, 2805-2811.
27. Roumiantsev S, Shah NP, Gorre ME, Nicoll J, Brasher BB, Sawyers CL and Van Etten RA. (2002). Proc. Natl. Acad. Sci. USA. 99, 10700-10705.
28. Sakaguchi N, Muramatsu H, Ichihara-Tanaka K, Maeda N, Noda M, Yamamoto T, Michikawa M, Ikematsu S, Sakuma S and Muramatsu T. (2003). Neurosci. Res., 45, 219-224.
29. Satoh J, Muramatsu H, Moretto G, Muramatsu T, Chang HJ, Kim ST, Cho JM and Kim SU. (1993). Brain. Res. Dev. Brain Res., 75, 201-205.
30. Schmitt E, Sane AT, Steyaert A, Cimoli G and Bertrand R. (1997). Biochem. Cell Biol., 75, 301-314.
31. Shannon KM. (2002). Cancer Cell, 2, 99-102.
32. Shay JW and Roninson IB. (2004). Oncogene, 23, 2919-2933.
33. Stoica GE, Kuo A, Powers C, Bowden ET, Sale EB, Riegel AT and Wellstein A. (2002). J. Biol. Chem., 277, 35990-35998.
34. Unoki K, Ohba N, Arimura H, Muramatsu H and Muramatsu T. (1994). Invest. Ophthalmol. Vis. Sci., 35, 4063-1068.
35. West KA, Castillo SS and Dennis PA. (2002). Drug Resist. Update, 5, 234-248.
36. Yaginuma H, Shiraiwa N, Shimada T, Nishiyama K, Hong J, Wang S, Momoi T, Uchiyama Y and Oppenheim RW. (2001). Mol. Cell Neurosci., 18, 168-182.